Abstract
Background
Antiretroviral therapy (ART) effectiveness is compromised by the emergence of HIV drug resistance mutations (DRM) and can lead to the failure of ART. Apart from intrinsic viral factors, non-compliance with drugs and/or the use of sub-optimum therapy can lead to the emergence of DRMs. In Pakistan HIV currently exists as a concentrated epidemic, however, ART coverage is very low, and drug adherence is poor. ART is selected assuming without baseline genotyping. Pakistan has recently seen a rise in treatment failures, but the country’s actual burden of DRM is still unknown. In this study, we perform the genetic and drug resistance analysis of the pol gene from Pakistani HIV-positive ART-naïve and ART-experienced individuals.
Methods
In this study, HIV-1 pol was sequenced from 146 HIV-1 positive individuals, divided into ART-naïve (n = 37) and ART-experienced (n = 109). The sequences were also used to determine HIV-1 subtypes, the prevalence of DRM, and pol genetic variability.
Results
DRM analysis identified numerous DRMs against reverse transcriptase inhibitors in both ART-naïve and ART-experienced groups, including a few that are classified as rare. Additionally, the ART-experienced group showed mutations associated with resistance to protease inhibitors. Genetic analysis showed negative selection pressure in both groups, but a higher rate of evolution in the ART-naïve group.
Conclusion
High prevalence of DRMs, especially against previous first-line treatment in ART- naïve and the accumulation of DRMs in ART-experienced groups is concerning and warrants that a more extensive DRM survey be carried out to inform first-line and second-line ART regimen recommendations.
Funder
Higher Education Commision, Pakistan
Pakistan Science Foundation
Higher Education Commission, Pakistan
Publisher
Public Library of Science (PLoS)
Reference70 articles.
1. Antiretroviral-drug resistance among patients recently infected with HIV;SJ Little;New England Journal of Medicine,2002
2. Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries;P Balakrishnan;Indian J Med Res,2005
3. Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India;M Vidya;Antiviral therapy,2009
4. Fidelity of HIV-1 reverse transcriptase;BD Preston;Science,1988